Evidence map›Paper›PMID 40810668›Full record

ArticleAntimicrobial agents and chemotherapy2025

Quality control and considering systematic MIC shifts are key when evaluating the role of

Thomas Schön, Paolo Miotto, Varvara K Kozyreva, Matthew D Sylvester, Daniela M Cirillo, Claudio U Köser

Abstract readLetter
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Thomas SchönDepartment of Biomedical and Clinical Sciences, Division of Infection and Inflammation, Linköping University, Linköping, Sweden.
Paolo MiottoEmerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0003-4610-2427
Varvara K KozyrevaMicrobial Diseases Laboratory Branch, California Department of Public Health, Richmond, California, USA.ORCID 0000-0003-3447-0070
Matthew D SylvesterMicrobial Diseases Laboratory Branch, California Department of Public Health, Richmond, California, USA.
Daniela M CirilloEmerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0001-6415-1535
Claudio U KöserDepartment of Biomedical and Clinical Sciences, Division of Infection and Inflammation, Linköping University, Linköping, Sweden.ORCID 0000-0002-0232-846X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bedaquilinegenotypic antimicrobial susceptibility testingMycobacterium tuberculosis

Identifiers

PMID40810668
PMCPMC12486809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.